AiM Medical Robotics (AiM) has signed an agreement with Siemens Healthineers to develop an interface that will allow AiM’s robotic neurosurgery platform to integrate with Siemens Healthineers’ magnetic resonance imaging (MRI) systems.
The collaboration focuses on connecting AiM’s MRI-compatible robotic stereotactic neurosurgery system with Siemens Healthineers’ range of MAGNETOM MRI scanners.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The new software interface is intended to enable data exchange and collaborative operation between the two technologies.
The integration will apply to Siemens Healthineers’ 1.5T, 3T, and 0.55T MRI systems, including the MAGNETOM Free.XL.
AiM stated that this interface is designed to facilitate real-time, in-bore neurosurgical procedures.
It supports precision image-guided therapies during interventions such as neurostimulator lead placement, tumour and epilepsy ablation, biopsies, and therapeutic delivery.
AiM founder and CEO Gregory Fischer said: “The opportunity to collaborate with a global technology leader like Siemens Healthineers further validates AiM’s technology and expands the ecosystem needed to bring next-generation precision robotics to image-guided operating suites worldwide.
“This collaboration accelerates our roadmap toward clinical deployment and reinforces AiM’s mission to make MRI-guided neurosurgery faster, safer, and more accessible.”
Siemens Healthineers indicated that it will continue to explore expanded software synchronisation and compatibility with AiM’s robotic platform under its third-party collaboration framework.
AiM specialises in developing MRI-compatible robotic platforms for neurosurgery, with its initial product focusing on enabling accurate, MRI-guided interventions.
The interface agreement marks a step towards enabling coordinated operation between robotics and imaging systems for neurosurgical procedures.
In May 2024, AiM Medical Robotics partnered with Harvard Medical School’s affiliate Brigham and Women’s Hospital in the US to conduct a study validating its robot for deep-brain stimulation in patients with Parkinson’s disease.
